Terms ending in 2036
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,683,368 | Fc-Region Variants with Modified Fcrn-Binding and Methods of Use In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,505,569 | Galnac Phosphoramidites, Nucleic Acid Conjugates Thereof and Their Use In force · Medium confidence | Hoffmann-La Roche, Inc. | In force | Medium confidence | |
| US 12,186,392 | Combination Therapy of an Anti CD20 Antibody with a BTK Inhibitor In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,441,812 | Methods of Treating Cancer by Administering Tumor Necrosis Factor (TNF) Family Ligand Trimer-Containing Antigen-Binding Molecules In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 10,190,182 | Novel Methods for Enzyme Mediated Polypeptide Conjugation In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,827,646 | Compounds for Treating Spinal Muscular Atrophy In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 12,461,109 | Vitro Prediction of in Vivo Half-Life In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,695,233 | Bispecific ANTI-VEGF/ANTI-ANG-2 Antibodies and Their Use in the Treatment of Ocular Vascular Diseases In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,328,420 | Quality Control of Automated Whole-slide Analyses In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 12,067,720 | Quality Control of Automated Whole-slide Analyses In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| 93 more term ends in 2036 · Pro | |||||
10 of 103 patents shown. Soonest term end first, then patent number.
Pro members see all 103.
96 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.